{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:48:19Z","timestamp":1791488899752,"version":"4.3.4"},"reference-count":148,"publisher":"American Association for Cancer Research (AACR)","issue":"12","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammation is associated with the development and malignant progression of most cancers. As most of the cell types involved in cancer-associated inflammation are genetically stable and thus are not subjected to rapid emergence of drug resistance, the targeting of inflammation represents an attractive strategy both for cancer prevention and for cancer therapy. Tumor-extrinsic inflammation is caused by many factors, including bacterial and viral infections, autoimmune diseases, obesity, tobacco smoking, asbestos exposure, and excessive alcohol consumption, all of which increase cancer risk and stimulate malignant progression. In contrast, cancer-intrinsic or cancer-elicited inflammation can be triggered by cancer-initiating mutations and can contribute to malignant progression through the recruitment and activation of inflammatory cells. Both extrinsic and intrinsic inflammation can result in immunosuppression, thereby providing a preferred background for tumor development. In clinical trials, lifestyle modifications including healthy diet, exercise, alcohol, and smoking cessation have proven effective in ameliorating inflammation and reducing the risk of cancer-related deaths. In addition, consumption of certain anti-inflammatory drugs, including aspirin, can significantly reduce cancer risk, suggesting that common nonsteroidal anti-inflammatory drugs (NSAID) and more specific COX2 inhibitors can be used in cancer prevention. In addition to being examined for their preventative potential, both NSAIDs and more potent anti-inflammatory antibody-based drugs need to be tested for their ability to augment the efficacy of more conventional therapeutic approaches on the basis of tumor resection, radiation, and cytotoxic chemicals. Cancer Prev Res; 9(12); 895\u2013905. \u00a92016 AACR.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-16-0209","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T07:47:59Z","timestamp":1478850479000},"page":"895-905","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":341,"title":["Targeting Inflammation in Cancer Prevention and Therapy"],"prefix":"10.1158","volume":"9","author":[{"given":"Jelena","family":"Todoric","sequence":"first","affiliation":[{"name":"1Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California."},{"name":"2Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Antonucci","sequence":"additional","affiliation":[{"name":"1Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Karin","sequence":"additional","affiliation":[{"name":"1Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California."},{"name":"3Department of Pathology, School of Medicine, University of California San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"2022060816321984400_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"2022060816321984400_bib2","first-page":"1","article-title":"In memoriam of Rudolf Virchow: a historical retrospective including aspects of inflammation, infection and neoplasia","volume":"13","author":"Schmidt","year":"2006","journal-title":"Contrib Microbiol"},{"key":"2022060816321984400_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2796.2010.02235.x","article-title":"Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination","volume":"268","author":"Norling","year":"2010","journal-title":"J Intern Med"},{"key":"2022060816321984400_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature17039","article-title":"Reparative inflammation takes charge of tissue regeneration","volume":"529","author":"Karin","year":"2016","journal-title":"Nature"},{"key":"2022060816321984400_bib5","first-page":"854","article-title":"Nitric oxide and oxygen radicals in infection, inflammation, and cancer","volume":"63","author":"Maeda","year":"1998","journal-title":"Biochemistry (Mosc)"},{"key":"2022060816321984400_bib6","doi-asserted-by":"crossref","first-page":"14007","DOI":"10.1073\/pnas.1211509109","article-title":"Chronic epithelial NF-kappaB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation","volume":"109","author":"Shaked","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060816321984400_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2022060816321984400_bib8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"2022060816321984400_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature11465","article-title":"Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth","volume":"491","author":"Grivennikov","year":"2012","journal-title":"Nature"},{"key":"2022060816321984400_bib10","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.immuni.2014.11.009","article-title":"Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis","volume":"41","author":"Wang","year":"2014","journal-title":"Immunity"},{"key":"2022060816321984400_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jso.2930180302","article-title":"The primary and secondary prevention of cancer","volume":"18","author":"Spratt","year":"1981","journal-title":"J Surg Oncol"},{"key":"2022060816321984400_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrclinonc.2013.169","article-title":"Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates","volume":"10","author":"Gronich","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"2022060816321984400_bib13","volume-title":"Obesity and overweight","author":"World Health Organization","year":"2015"},{"key":"2022060816321984400_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1470-2045(14)71123-4","article-title":"Global burden of cancer attributable to high body-mass index in 2012: a population-based study","volume":"16","author":"Arnold","year":"2015","journal-title":"Lancet Oncol"},{"key":"2022060816321984400_bib15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"2022060816321984400_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cmet.2015.12.015","article-title":"Obesity and cancer: the oil that feeds the flame","volume":"23","author":"Font-Burgada","year":"2016","journal-title":"Cell Metab"},{"key":"2022060816321984400_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.immuni.2014.05.010","article-title":"Macrophages, immunity, and metabolic disease","volume":"41","author":"McNelis","year":"2014","journal-title":"Immunity"},{"key":"2022060816321984400_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"key":"2022060816321984400_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccr.2009.12.048","article-title":"Hepatocyte IKKbeta\/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation","volume":"17","author":"He","year":"2010","journal-title":"Cancer Cell"},{"key":"2022060816321984400_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2022060816321984400_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1665-2681(19)31267-0","article-title":"Obesity as a cause of hepatocellular carcinoma","volume":"14","author":"Kew","year":"2015","journal-title":"Ann Hepatol"},{"key":"2022060816321984400_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3945\/ajcn.110.002683","article-title":"Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis","volume":"93","author":"Pendyala","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"2022060816321984400_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/obr.12242","article-title":"Macrophage recruitment in obese adipose tissue","volume":"16","author":"Bai","year":"2015","journal-title":"Obes Rev"},{"key":"2022060816321984400_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(09)70159-7","article-title":"Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial","volume":"10","author":"Sjostrom","year":"2009","journal-title":"Lancet Oncol"},{"key":"2022060816321984400_bib25","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00125-006-0300-x","article-title":"Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids","volume":"49","author":"Todoric","year":"2006","journal-title":"Diabetologia"},{"key":"2022060816321984400_bib26","doi-asserted-by":"crossref","first-page":"e7250","DOI":"10.1371\/journal.pone.0007250","article-title":"12\/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice","volume":"4","author":"Sears","year":"2009","journal-title":"PLoS One"},{"key":"2022060816321984400_bib27","article-title":"Guidelines JDRCD"},{"key":"2022060816321984400_bib28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.4254\/wjh.v7.i8.1105","article-title":"Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: role of statins and metformin","volume":"7","author":"Ampuero","year":"2015","journal-title":"World J Hepatol"},{"key":"2022060816321984400_bib29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1055-9965.EPI-08-0347","article-title":"Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium","volume":"18","author":"Hashibe","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816321984400_bib30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cld.2012.08.011","article-title":"Liver cancer and alcohol","volume":"16","author":"Grewal","year":"2012","journal-title":"Clin Liver Dis"},{"key":"2022060816321984400_bib31","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.bjc.6600596","article-title":"Alcohol, tobacco and breast cancer\u2013collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease","volume":"87","author":"Hamajima","year":"2002","journal-title":"Br J Cancer"},{"key":"2022060816321984400_bib32","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(11)60022-6","article-title":"Projections of alcohol deaths\u2013a wake-up call","volume":"377","author":"Sheron","year":"2011","journal-title":"Lancet"},{"key":"2022060816321984400_bib33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cld.2012.08.004","article-title":"Histologic findings in alcoholic liver disease","volume":"16","author":"Crawford","year":"2012","journal-title":"Clin Liver Dis"},{"key":"2022060816321984400_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-0035-1550054","article-title":"Liver fibrosis in alcoholic liver disease","volume":"35","author":"Bataller","year":"2015","journal-title":"Semin Liver Dis"},{"key":"2022060816321984400_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.1840130211","article-title":"Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients","volume":"13","author":"Khoruts","year":"1991","journal-title":"Hepatology"},{"key":"2022060816321984400_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ccr.2011.03.018","article-title":"The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment","volume":"19","author":"Li","year":"2011","journal-title":"Cancer Cell"},{"key":"2022060816321984400_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","article-title":"ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development","volume":"26","author":"Nakagawa","year":"2014","journal-title":"Cancer Cell"},{"key":"2022060816321984400_bib38","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","author":"European Association for the Study of L","year":"2012","journal-title":"J Hepatol"},{"key":"2022060816321984400_bib39","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"key":"2022060816321984400_bib40","doi-asserted-by":"crossref","first-page":"G1248","DOI":"10.1152\/ajpgi.90223.2008","article-title":"Inflammasome-mediated regulation of hepatic stellate cells","volume":"296","author":"Watanabe","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022060816321984400_bib41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.alcohol.2008.03.131","article-title":"Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium","volume":"42","author":"Purohit","year":"2008","journal-title":"Alcohol"},{"key":"2022060816321984400_bib42","doi-asserted-by":"crossref","first-page":"27923","DOI":"10.1038\/srep27923","article-title":"Ecophysiological consequences of alcoholism on human gut microbiota: implications for ethanol-related pathogenesis of colon cancer","volume":"6","author":"Tsuruya","year":"2016","journal-title":"Sci Rep"},{"key":"2022060816321984400_bib43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/1471-2407-11-446","article-title":"How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature","volume":"11","author":"Heckley","year":"2011","journal-title":"BMC Cancer"},{"key":"2022060816321984400_bib44","first-page":"654","article-title":"Management of alcohol use disorders in patients with chronic pancreatitis","volume":"13","author":"Lang","year":"2012","journal-title":"JOP"},{"key":"2022060816321984400_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/mc.20786","article-title":"Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer","volume":"51","author":"Duell","year":"2012","journal-title":"Mol Carcinog"},{"key":"2022060816321984400_bib46","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.ajpath.2013.07.023","article-title":"Alcohol exacerbates LPS-induced fibrosis in subclinical acute pancreatitis","volume":"183","author":"Gu","year":"2013","journal-title":"Am J Pathol"},{"key":"2022060816321984400_bib47","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1164\/ajrccm.155.5.9154890","article-title":"Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells","volume":"155","author":"Mio","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2022060816321984400_bib48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1465-9921-7-132","article-title":"Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells","volume":"7","author":"Kode","year":"2006","journal-title":"Respir Res"},{"key":"2022060816321984400_bib49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2567.2007.02788.x","article-title":"Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells","volume":"124","author":"Pace","year":"2008","journal-title":"Immunology"},{"key":"2022060816321984400_bib50","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/0022034511421200","article-title":"Cigarette smoking and inflammation: cellular and molecular mechanisms","volume":"91","author":"Lee","year":"2012","journal-title":"J Dent Res"},{"key":"2022060816321984400_bib51","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1165\/rcmb.2010-0231OC","article-title":"Receptor for advanced glycation end-products signals through Ras during tobacco smoke-induced pulmonary inflammation","volume":"45","author":"Reynolds","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2022060816321984400_bib52","first-page":"4682","article-title":"ras oncogenes in human cancer: a review","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Res"},{"key":"2022060816321984400_bib53","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1124\/mol.105.012591","article-title":"Cigarette smoke activates human monocytes by an oxidant-AP-1 signaling pathway: implications for steroid resistance","volume":"68","author":"Walters","year":"2005","journal-title":"Mol Pharmacol"},{"key":"2022060816321984400_bib54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ccr.2009.12.008","article-title":"Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation","volume":"17","author":"Takahashi","year":"2010","journal-title":"Cancer Cell"},{"key":"2022060816321984400_bib55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc703","article-title":"Helicobacter pylori and gastrointestinal tract adenocarcinomas","volume":"2","author":"Peek","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2022060816321984400_bib56","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"2022060816321984400_bib57","doi-asserted-by":"crossref","first-page":"R488","DOI":"10.1016\/j.cub.2011.05.039","article-title":"Toll-like receptors","volume":"21","author":"Moresco","year":"2011","journal-title":"Curr Biol"},{"key":"2022060816321984400_bib58","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1084\/jem.20111706","article-title":"MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells","volume":"209","author":"Ochi","year":"2012","journal-title":"J Exp Med"},{"key":"2022060816321984400_bib59","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1053\/j.gastro.2007.09.008","article-title":"Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors","volume":"133","author":"Fukata","year":"2007","journal-title":"Gastroenterology"},{"key":"2022060816321984400_bib60","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/jcmm.12117","article-title":"Immune cells: plastic players along colorectal cancer progression","volume":"17","author":"Di Caro","year":"2013","journal-title":"J Cell Mol Med"},{"key":"2022060816321984400_bib61","doi-asserted-by":"crossref","first-page":"9862","DOI":"10.1073\/pnas.1307575110","article-title":"Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer","volume":"110","author":"Hu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060816321984400_bib62","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1224820","article-title":"Intestinal inflammation targets cancer-inducing activity of the microbiota","volume":"338","author":"Arthur","year":"2012","journal-title":"Science"},{"key":"2022060816321984400_bib63","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.chom.2014.02.007","article-title":"Microbes, microbiota, and colon cancer","volume":"15","author":"Sears","year":"2014","journal-title":"Cell Host Microbe"},{"key":"2022060816321984400_bib64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bpg.2016.02.009","article-title":"Probiotics, prebiotics and colorectal cancer prevention","volume":"30","author":"Ambalam","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2022060816321984400_bib65","volume-title":"Report of a Joint FAO\/WHO expert consultation on evaluation of health, and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria","author":"FAO\/WHO","year":"2001"},{"key":"2022060816321984400_bib66","doi-asserted-by":"crossref","first-page":"830S","DOI":"10.1093\/jn\/137.3.830S","article-title":"Prebiotics: the concept revisited","volume":"137","author":"Roberfroid","year":"2007","journal-title":"J Nutr"},{"key":"2022060816321984400_bib67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3945\/an.112.003046","article-title":"The interplay between fiber and the intestinal microbiome in the inflammatory response","volume":"4","author":"Kuo","year":"2013","journal-title":"Adv Nutr"},{"key":"2022060816321984400_bib68","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.molmed.2016.05.007","article-title":"Exercise-dependent regulation of NK cells in cancer protection","volume":"22","author":"Idorn","year":"2016","journal-title":"Trends Mol Med"},{"key":"2022060816321984400_bib69","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1158\/1078-0432.CCR-16-0067","article-title":"Physical activity and cancer outcomes: a precision medicine approach","volume":"22","author":"Friedenreich","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2022060816321984400_bib70","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI31537","article-title":"A cytokine-mediated link between innate immunity, inflammation, and cancer","volume":"117","author":"Lin","year":"2007","journal-title":"J Clin Invest"},{"key":"2022060816321984400_bib71","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2016.01.011","article-title":"Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution","volume":"23","author":"Pedersen","year":"2016","journal-title":"Cell Metab"},{"key":"2022060816321984400_bib72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"2022060816321984400_bib73","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/carcin\/bgw042","article-title":"The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice","volume":"37","author":"Guo","year":"2016","journal-title":"Carcinogenesis"},{"key":"2022060816321984400_bib74","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bpg.2011.10.016","article-title":"Pharmacology and cellular\/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer","volume":"25","author":"Schror","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2022060816321984400_bib75","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2045-3701-3-8","article-title":"Non-steroid anti-inflammatory drugs, prostaglandins, and cancer","volume":"3","author":"Allaj","year":"2013","journal-title":"Cell Biosci"},{"key":"2022060816321984400_bib76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1734-1140(10)70262-0","article-title":"COX-2 as a target for cancer chemotherapy","volume":"62","author":"Ghosh","year":"2010","journal-title":"Pharmacol Rep"},{"key":"2022060816321984400_bib77","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"2022060816321984400_bib78","first-page":"238","article-title":"Virtual dual inhibition of COX-2\/5-LOX enzymes based on binding properties of alpha-amyrins, the anti-inflammatory compound as a promising anti-cancer drug","volume":"15","author":"Ranjbar","year":"2016","journal-title":"EXCLI J"},{"key":"2022060816321984400_bib79","doi-asserted-by":"crossref","first-page":"e1001098","DOI":"10.1371\/journal.pmed.1001098","article-title":"Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies","volume":"8","author":"McGettigan","year":"2011","journal-title":"PLoS Med"},{"key":"2022060816321984400_bib80","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djj206","article-title":"Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors","volume":"98","author":"Grosch","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2022060816321984400_bib81","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4255\/mcpharmacol.09.05","article-title":"Anti-inflammatory agents for cancer therapy","volume":"1","author":"Rayburn","year":"2009","journal-title":"Mol Cell Pharmacol"},{"key":"2022060816321984400_bib82","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1158\/1078-0432.CCR-0829-3","article-title":"Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy","volume":"10","author":"Wang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2022060816321984400_bib83","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/08958370590899712","article-title":"The chemopreventive effects of orally administered dexamethasone in Strain A\/J mice following cessation of smoke exposure","volume":"17","author":"Witschi","year":"2005","journal-title":"Inhal Toxicol"},{"key":"2022060816321984400_bib84","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1411321","article-title":"Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma","volume":"372","author":"Stewart","year":"2015","journal-title":"N Engl J Med"},{"key":"2022060816321984400_bib85","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12890-015-0153-5","article-title":"The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma","volume":"15","author":"Jian","year":"2015","journal-title":"BMC Pulm Med"},{"key":"2022060816321984400_bib86","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"2022060816321984400_bib87","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"2022060816321984400_bib88","first-page":"212","article-title":"Reflections from the Dean's office","volume":"40","author":"Massey","year":"1976","journal-title":"Conn Med"},{"key":"2022060816321984400_bib89","doi-asserted-by":"crossref","first-page":"II18","DOI":"10.1161\/01.CIR.0000129505.34151.23","article-title":"Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?","volume":"109","author":"Schonbeck","year":"2004","journal-title":"Circulation"},{"key":"2022060816321984400_bib90","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2012.44.6831","article-title":"Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection","volume":"31","author":"Tsan","year":"2013","journal-title":"J Clin Oncol"},{"key":"2022060816321984400_bib91","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1056\/NEJMoa043792","article-title":"Statins and the risk of colorectal cancer","volume":"352","author":"Poynter","year":"2005","journal-title":"N Engl J Med"},{"key":"2022060816321984400_bib92","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1200\/JCO.2005.02.7045","article-title":"Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies","volume":"23","author":"Bonovas","year":"2005","journal-title":"J Clin Oncol"},{"key":"2022060816321984400_bib93","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ctrv.2013.05.006","article-title":"The impact of anti-inflammatory agents on the outcome of patients with colorectal cancer","volume":"40","author":"Park","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"2022060816321984400_bib94","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11864-015-0359-z","article-title":"The role of aspirin, vitamin D, exercise, diet, statins, and metformin in the prevention and treatment of colorectal cancer","volume":"16","author":"Sehdev","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"2022060816321984400_bib95","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/CCO.0b013e32834d8155","article-title":"Metformin and cancer therapy","volume":"24","author":"Bost","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"2022060816321984400_bib96","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"2022060816321984400_bib97","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2022060816321984400_bib98","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ni.2705","article-title":"Tissue-resident macrophages","volume":"14","author":"Davies","year":"2013","journal-title":"Nat Immunol"},{"key":"2022060816321984400_bib99","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol"},{"key":"2022060816321984400_bib100","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers (Basel)"},{"key":"2022060816321984400_bib101","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"2022060816321984400_bib102","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/icb.2014.22","article-title":"Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion","volume":"92","author":"Karnevi","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"2022060816321984400_bib103","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"2022060816321984400_bib104","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"2022060816321984400_bib105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1084\/jem.20150295","article-title":"The interaction of anticancer therapies with tumor-associated macrophages","volume":"212","author":"Mantovani","year":"2015","journal-title":"J Exp Med"},{"key":"2022060816321984400_bib106","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","article-title":"Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2\/CCR2 axis","volume":"19","author":"Sanford","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2022060816321984400_bib107","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood"},{"key":"2022060816321984400_bib108","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coi.2014.05.009","article-title":"Impact of myeloid cells on the efficacy of anticancer chemotherapy","volume":"30","author":"Senovilla","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"2022060816321984400_bib109","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1158\/2326-6066.CIR-14-0036","article-title":"Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models","volume":"3","author":"Shen","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"2022060816321984400_bib110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-015-0098-5","article-title":"Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment","volume":"3","author":"Olsson","year":"2015","journal-title":"J Immunother Cancer"},{"key":"2022060816321984400_bib111","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/carcin\/bgr128","article-title":"COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin\/+ mouse polyps","volume":"32","author":"Nakanishi","year":"2011","journal-title":"Carcinogenesis"},{"key":"2022060816321984400_bib112","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00262-009-0667-x","article-title":"Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta","volume":"58","author":"Nagai","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"2022060816321984400_bib113","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1196\/annals.1378.063","article-title":"Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution","volume":"1091","author":"Aggarwal","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2022060816321984400_bib114","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"2022060816321984400_bib115","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1517\/13543784.2011.601739","article-title":"Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors","volume":"20","author":"Mankan","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"2022060816321984400_bib116","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","article-title":"IL-6 and related cytokines as the critical lynchpins between inflammation and cancer","volume":"26","author":"Taniguchi","year":"2014","journal-title":"Semin Immunol"},{"key":"2022060816321984400_bib117","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20110283","article-title":"Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas","volume":"208","author":"Pilati","year":"2011","journal-title":"J Exp Med"},{"key":"2022060816321984400_bib118","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ccr.2008.12.018","article-title":"Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment","volume":"15","author":"Kortylewski","year":"2009","journal-title":"Cancer Cell"},{"key":"2022060816321984400_bib119","first-page":"e22882","article-title":"STAT3 inhibitors for cancer therapy: Have all roads been explored?","volume":"2","author":"Fagard","year":"2013","journal-title":"JAKSTAT"},{"key":"2022060816321984400_bib120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrd3652","article-title":"Ruxolitinib","volume":"11","author":"Mesa","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"2022060816321984400_bib121","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/eci.12.19","article-title":"Tofacitinib for the treatment of rheumatoid arthritis","volume":"8","author":"Zerbini","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"2022060816321984400_bib122","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/pbc.25575","article-title":"A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)","volume":"62","author":"Loh","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"2022060816321984400_bib123","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1634\/theoncologist.2013-0198","article-title":"AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors","volume":"18","author":"Plimack","year":"2013","journal-title":"Oncologist"},{"key":"2022060816321984400_bib124","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jcb.21695","article-title":"NF-kappaB and epithelial to mesenchymal transition of cancer","volume":"104","author":"Min","year":"2008","journal-title":"J Cell Biochem"},{"key":"2022060816321984400_bib125","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2015.12.057","article-title":"NF-kappaB restricts inflammasome activation via elimination of damaged mitochondria","volume":"164","author":"Zhong","year":"2016","journal-title":"Cell"},{"key":"2022060816321984400_bib126","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ni.1976","article-title":"IL-1beta-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKbeta","volume":"12","author":"Hsu","year":"2011","journal-title":"Nat Immunol"},{"key":"2022060816321984400_bib127","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood-2006-02-003988","article-title":"Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells","volume":"109","author":"Bhardwaj","year":"2007","journal-title":"Blood"},{"key":"2022060816321984400_bib128","first-page":"4375","article-title":"Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1","volume":"63","author":"Shishodia","year":"2003","journal-title":"Cancer Res"},{"key":"2022060816321984400_bib129","doi-asserted-by":"crossref","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","article-title":"Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]","volume":"270","author":"Singh","year":"1995","journal-title":"J Biol Chem"},{"key":"2022060816321984400_bib130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.trsl.2011.12.003","article-title":"Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis","volume":"159","author":"Salamone","year":"2012","journal-title":"Transl Res"},{"key":"2022060816321984400_bib131","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/MPA.0b013e318249d62e","article-title":"Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer","volume":"41","author":"Ahn","year":"2012","journal-title":"Pancreas"},{"key":"2022060816321984400_bib132","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1078-0432.CCR-08-0149","article-title":"Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe","volume":"15","author":"Aggarwal","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2022060816321984400_bib133","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2022060816321984400_bib134","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4161\/auto.28374","article-title":"Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer","volume":"10","author":"Guo","year":"2014","journal-title":"Autophagy"},{"key":"2022060816321984400_bib135","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.febslet.2012.02.045","article-title":"TLR-induced NF-kappaB activation regulates NLRP3 expression in murine macrophages","volume":"586","author":"Qiao","year":"2012","journal-title":"FEBS Lett"},{"key":"2022060816321984400_bib136","doi-asserted-by":"crossref","first-page":"654963","DOI":"10.1155\/2013\/654963","article-title":"Inflammasome in intestinal inflammation and cancer","volume":"2013","author":"Nunes","year":"2013","journal-title":"Mediators Inflamm"},{"key":"2022060816321984400_bib137","doi-asserted-by":"crossref","first-page":"E6166","DOI":"10.1073\/pnas.1519384112","article-title":"Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress","volume":"112","author":"Antonucci","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060816321984400_bib138","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1172\/JCI64498","article-title":"Loss of acinar cell IKKalpha triggers spontaneous pancreatitis in mice","volume":"123","author":"Li","year":"2013","journal-title":"J Clin Invest"},{"key":"2022060816321984400_bib139","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1440-1746.2011.07008.x","article-title":"Obesity, autophagy and the pathogenesis of liver and pancreatic cancers","volume":"2","author":"Aghajan","year":"2012","journal-title":"J Gastroenterol Hepatol 27 Suppl"},{"key":"2022060816321984400_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem J"},{"key":"2022060816321984400_bib141","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: advances and new agents","volume":"12","author":"Crusz","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"2022060816321984400_bib142","first-page":"S87","article-title":"The IL-23 to IL-17 cascade inflammation-related cancers","volume":"33","author":"Wang","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2022060816321984400_bib143","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat Med"},{"key":"2022060816321984400_bib144","doi-asserted-by":"crossref","first-page":"e1003784","DOI":"10.1371\/journal.ppat.1003784","article-title":"Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?","volume":"9","author":"Bertoletti","year":"2013","journal-title":"PLoS Pathog"},{"key":"2022060816321984400_bib145","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group","volume":"336","author":"Chang","year":"1997","journal-title":"N Engl J Med"},{"key":"2022060816321984400_bib146","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4254\/wjh.v7.i8.1030","article-title":"Current and future antiviral drug therapies of hepatitis B chronic infection","volume":"7","author":"Koumbi","year":"2015","journal-title":"World J Hepatol"},{"key":"2022060816321984400_bib147","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"key":"2022060816321984400_bib148","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2005.09.054","article-title":"The epidemiology of genital human papillomavirus infection","volume":"24","author":"Trottier","year":"2006","journal-title":"Vaccine"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/9\/12\/895\/1735620\/895.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/9\/12\/895\/1735620\/895.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T10:37:39Z","timestamp":1718879859000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/9\/12\/895\/50497\/Targeting-Inflammation-in-Cancer-Prevention-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":148,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,1]]},"published-print":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-16-0209","relation":{},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}